×
About 340 results
BINOSTO® (alendronate sodium)
https://www.binosto.com/content/healthcare-professionals

You know the risks are real. Osteoporosis can change a woman's world. With BINOSTO ® you can strengthen her world with the proven power of alendronate in a buffered effervescent solution. Now, you can give your patients:

DUAVEE® (conjugated estrogens/bazedoxifene)
https://www1.pfizerpro.com/product/duavee/hcp

DUAVEE contains bazedoxifene, an estrogen agonist/antagonist, to reduce the risk of endometrial hyperplasia that can occur with estrogens, and which may be ...

PREMARIN® (conjugated estrogens tablets, USP)
https://www.pfizerpro.com/product/premarin/hcp

Help patients save on PREMARIN® (conjugated estrogens tablets, USP), order ... of vulvar and vaginal atrophy, topical vaginal products should be considered.

Forteo® (teriparatide [rDNA origin] injection)
https://www.forteo.com/hcp/

FORTEO [teriparatide (rDNA origin) injection] can be used to treat postmenopausal women with osteoporosis at high risk for fracture, to increase bone mass in ...

BONIVA (ibandronate sodium) TABLETS
https://www.gene.com/medical-professionals/medicines/boniva-tablets

Medical Professionals / Our Medicines ... BONIVA(R) F. C. Tablets (150 mg) ... The safety and effectiveness of Boniva for the treatment of osteoporosis are based ...

PROLIA® (denosumab) Injection
http://www.proliahcp.com

Treatment for women with postmenopausal osteoporosis and treatment to increase bone mass in men with osteoporosis at high risk for fracture.

TYMLOS™ (abaloparatide) INJECTION
https://www.tymloshcp.com/

TYMLOS is an osteoporosis treatment for postmenopausal women at high risk of fracture. To find if it's right for your patients, click here. See Warning and Important Safety.

EVENITY (romosozumab-aqqg)
https://www.evenityhcp.com/

EVENITY (romosozumab) is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture

Duavee - conjugated estrogens/bazedoxifene tablet, film coated-U.S. Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e16705d8-4472-4f83-96ac-69fa2be066cb

Dec 10th, 2019 - DUAVEE is indicated in women with a uterus for: DUAVEE is a combination of conjugated estrogens with an estrogen agonist/antagonist indicated for treatment of the following conditions in women with a uterus: Treatment of moderate to severe vasomotor symptoms associated with menopause (1.1) Prevention of postmenopausal osteoporosis (1.2) Limitation of Use: DUAVEE should be used for the shortest ...

Raloxifene hydrochloride - raloxifene hydrochloride tablet, film coated-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5a65cd5b-0f9e-46ac-ae01-8b2223186c41

Dec 10th, 2019 - Raloxifene hydrochloride tablets are an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. (1.1) Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. (1.2) Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer. (1.3) Important Limitations: Raloxifene ...

Alora - estradiol patch-Allergan, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ac676026-14be-486a-9d64-6702bd9e51ea

Dec 9th, 2019 - Alora is indicated in: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Treatment of hypoestrogenism due to hypogonadism, castrati...

Alora - estradiol patch-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a0d4f0b8-5dcc-4ffe-9590-0203e869622f

Dec 9th, 2019 - Alora is indicated in: Treatment of moderate to severe vasomotor symptoms associated with the menopause. Treatment of moderate to severe symptoms of vulvar and vaginal atrophy associated with the menopause. When prescribing solely for the treatment of symptoms of vulvar and vaginal atrophy, topical vaginal products should be considered. Treatment of hypoestrogenism due to hypogonadism, castrati...

Binosto - alendronate sodium tablet, effervescent-ASCEND Therapeutics
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b278a11a-b8d7-49f3-9b38-29b67c4c417e

Dec 9th, 2019 - BINOSTO is a bisphosphonate indicated for: Treatment of osteoporosis in postmenopausal women ( 1.1) Treatment to increase bone mass in men with osteoporosis ( 1.2) Limitation of use: Optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use. ( 1.3) BINOSTO effervescent tablet 70 mg is indicated for the treatme...

Amabelz - estradiol and norethindrone acetate tablet-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3b8a7426-6f1c-470a-ac36-b8465b8679cd

Dec 9th, 2019 - Amabelz is an estrogen and progestin combination indicated in a woman with a uterus for: Amabelz 1 mg/0.5 mg and 0.5 mg/0.1 mg are indicated in a woman with a uterus for: •    Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1)     •    Prevention of Postmenopausal Osteoporosis (1.3) Amabelz 1 mg/0.5 mg is also indicated in a woman with a uterus for:     •    Treatment of ...

Minivelle - estradiol film, extended release-Noven Therapeutics, LLC
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=6c5c47ab-28ee-11e1-bfc2-0800200c9a66

Dec 8th, 2019 - MINIVELLE® is an estrogen indicated for: Treatment of moderate to severe vasomotor symptoms due to menopause (1.1) Prevention of postmenopausal osteoporosis (1.2) MINIVELLE is indicated for the treatment of moderate to severe vasomotor symptoms due to menopause. MINIVELLE is indicated for the prevention of postmenopausal osteoporosis. When prescribing solely for the prevention of postmenopausal...

Evista - raloxifene hydrochloride tablet-Eli Lilly and Company
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fcaaa6dc-74e8-4fb8-800c-5574bf0f8de9

Dec 8th, 2019 - EVISTA® is an estrogen agonist/antagonist indicated for: Treatment and prevention of osteoporosis in postmenopausal women. (1.1) Reduction in risk of invasive breast cancer in postmenopausal women with osteoporosis. (1.2) Reduction in risk of invasive breast cancer in postmenopausal women at high risk for invasive breast cancer. (1.3) Important Limitations: EVISTA is not indicated for the treat...

Alendronate sodium - alendronate sodium tablet-A-S Medication Solutions
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fe1dd324-eb02-4a73-97f5-9b77a7df10a7

Dec 4th, 2019 - Alendronate sodium is a bisphosphonate indicated for: Treatment and prevention of osteoporosis in postmenopausal women (1.1, 1.2) Treatment to increase bone mass in men with osteoporosis (1.3) Treatment of glucocorticoid-induced osteoporosis (1.4) Treatment of Paget's disease of bone (1.5) Limitations of use: Optimal duration of use has not been determined. For patients at low- risk for fractur...

Boniva - ibandronate sodium tablet, film coated-Genentech, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=841bf769-0148-42a8-a4d0-ff062b4734e8

Dec 4th, 2019 - BONIVA is a bisphosphonate indicated for the treatment and prevention of postmenopausal osteoporosis. (1.1). Limitations of Use The optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use. (1.2). BONIVA is indicated for the treatment and prevention of osteoporosis in postmenopausal women. BONIVA increases bo...

Premphase - conjugated estrogens and medroxyprogesterone acetate kit-Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fd0c0836-5d23-2183-da81-9dc7f4287052

Dec 3rd, 2019 - PREMPRO/PREMPHASE is an estrogen plus progestin indicated in a woman with a uterus for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1) Treatment of Moderate to Severe Vulvar and Vaginal Atrophy due to Menopause (1.2) Prevention of Postmenopausal Osteoporosis (1.3)

Fyavolv - norethindrone acetate and ethinyl estradiol tablet, film coated-Lupin Pharmaceuticals, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=772c86d7-10a4-48c5-8c19-f8aac68f5ab4

Nov 26th, 2019 - Fyavolv is an estrogen plus progestin indicated in a woman with a uterus for: Treatment of Moderate to Severe Vasomotor Symptoms due to Menopause (1.1) Prevention of Postmenopausal Osteoporosis (1.2) Limitation of Use When prescribing solely for the prevention of postmenopausal osteoporosis, therapy should only be considered for women at significant risk of osteoporosis and non-estrogen medicat...